Amanda Hillen
Psychiatric/Mental Health · Mc Murray, PANPI 1598319154
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 72.9% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $8,073 and has fallen 96.0% since, to $323 in 2024. Among psychiatric/mental health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 409 payments — averaging $42.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$13K
- Otsuka America Pharmaceutical, Inc.$770
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$749
- Alkermes, Inc.$658
- Takeda Pharmaceuticals U.S.A., Inc.$446
- Johnson & Johnson$431
- plus $2K from 11 others
What the payments were for
- Speaking & faculty fees$9,07553%
- Travel & lodging$1,0856%
- Food & beverage$7,09541%
- Education$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 140 | $12,575 |
| Otsuka America Pharmaceutical, Inc. | 49 | $770 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $749 |
| Alkermes, Inc. | 21 | $658 |
| Takeda Pharmaceuticals U.S.A., Inc. | 41 | $446 |
| Johnson & Johnson | 27 | $431 |
| Sunovion Pharmaceuticals Inc. | 25 | $320 |
| Neurocrine Biosciences, Inc. | 20 | $319 |
| Vanda Pharmaceuticals Inc. | 15 | $283 |
| Lundbeck LLC | 15 | $233 |
| Indivior Inc. | 9 | $158 |
| Corium, LLC | 7 | $128 |
| Almatica Pharma LLC | 4 | $71 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Sage Therapeutics, LLC | 1 | $26 |
| Alfasigma USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$10,371
- LYBALVI$422
- CAPLYTA$361
- ABILIFY MAINTENA$123
- SPRAVATO$104
How this compares
$17,258 in reported general payments places this provider in the 95th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $381 |
| Duloxetine Hcl | 11 | $345 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Mc Murray
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Anna DipietroDowningtown$131K
- Deena MasciocchiLanghorne$71K
- Joseph GagnonChesterbrook$64K
- Michelle CohenWashington$62K
- Sharon KatzJenkintown$51K
- Jennifer BowmanCanonsburg$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.